Literature DB >> 26662051

Chronic nicotine exposure exacerbates transient focal cerebral ischemia-induced brain injury.

Chun Li1, Hong Sun1, Denise M Arrick1, William G Mayhan2.   

Abstract

Tobacco smoking is a risk factor contributing to the development and progression of ischemic stroke. Among many chemicals in tobacco, nicotine may be a key contributor. We hypothesized that nicotine alters the balance between oxidant and antioxidant networks leading to an increase in brain injury following transient focal cerebral ischemia. Male Sprague-Dawley were treated with nicotine (2 or 4 mg·kg(-1)·day(-1)) for 4 wk via an implanted subcutaneous osmotic minipump and subjected to a 2-h middle cerebral artery occlusion (MCAO). Infarct size and neurological deficits were evaluated at 24 h of reperfusion. Superoxide levels were determined by lucigenin-enhanced chemiluminescence. Expression of oxidant and antioxidant proteins was measured using Western blot analysis. We found that chronic nicotine exposure significantly increased infarct size and worsened neurological deficits. In addition, nicotine significantly elevated superoxide levels of cerebral cortex under basal conditions. Transient focal cerebral ischemia produced an increase in superoxide levels of cerebral cortex in control group, but no further increase was found in the nicotine group. Furthermore, chronic nicotine exposure did not alter protein expression of NADPH oxidase but significantly decreased MnSOD and uncoupling protein-2 (UCP-2) in the cerebral cortex and cerebral arteries. Our findings suggest that nicotine-induced exacerbation in brain damage following transient focal cerebral ischemia may be related to a preexisting oxidative stress via decreasing of MnSOD and UCP-2.
Copyright © 2016 the American Physiological Society.

Entities:  

Keywords:  MnSOD; UCP-2; ischemia; nicotine; oxidative stress; reperfusion

Mesh:

Substances:

Year:  2015        PMID: 26662051     DOI: 10.1152/japplphysiol.00663.2015

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  7 in total

1.  Signal of Carotid Intraplaque Hemorrhage on MR T1-Weighted Imaging: Association with Acute Cerebral Infarct.

Authors:  D Yang; Y Liu; Y Han; D Li; W Wang; R Li; C Yuan; X Zhao
Journal:  AJNR Am J Neuroradiol       Date:  2020-04-09       Impact factor: 3.825

2.  Discrimination of smoking status by MRI based on deep learning method.

Authors:  Shuangkun Wang; Rongguo Zhang; Yufeng Deng; Kuan Chen; Dan Xiao; Peng Peng; Tao Jiang
Journal:  Quant Imaging Med Surg       Date:  2018-12

3.  Inhibition of miRNA-210 reverses nicotine-induced brain hypoxic-ischemic injury in neonatal rats.

Authors:  Lei Wang; Jun Ke; Yong Li; Qinyi Ma; Chiranjib Dasgupta; Xiaohui Huang; Lubo Zhang; DaLiao Xiao
Journal:  Int J Biol Sci       Date:  2017-01-01       Impact factor: 6.580

4.  Offsetting the impact of smoking and e-cigarette vaping on the cerebrovascular system and stroke injury: Is Metformin a viable countermeasure?

Authors:  Mohammad A Kaisar; Heidi Villalba; Shikha Prasad; Taylor Liles; Ali Ehsan Sifat; Ravi K Sajja; Thomas J Abbruscato; Luca Cucullo
Journal:  Redox Biol       Date:  2017-06-17       Impact factor: 11.799

Review 5.  Brain Energy Metabolism in Ischemic Stroke: Effects of Smoking and Diabetes.

Authors:  Ali Ehsan Sifat; Saeideh Nozohouri; Sabrina Rahman Archie; Ekram Ahmed Chowdhury; Thomas J Abbruscato
Journal:  Int J Mol Sci       Date:  2022-07-31       Impact factor: 6.208

6.  Short-term exposure to JUUL electronic cigarettes can worsen ischemic stroke outcome.

Authors:  Ali Ehsan Sifat; Sabrina Rahman Archie; Saeideh Nozohouri; Heidi Villalba; Yong Zhang; Sejal Sharma; Yashwardhan Ghanwatkar; Bhuvaneshwar Vaidya; David Mara; Luca Cucullo; Thomas J Abbruscato
Journal:  Fluids Barriers CNS       Date:  2022-09-09

7.  A convenient UHPLC-MS/MS method for routine monitoring of plasma and brain levels of nicotine and cotinine as a tool to validate newly developed preclinical smoking model in mouse.

Authors:  Mohammad A Kaisar; Raja Reddy Kallem; Ravi K Sajja; Ali Ehsan Sifat; Luca Cucullo
Journal:  BMC Neurosci       Date:  2017-10-11       Impact factor: 3.288

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.